广东多措施推动医药分开 职工与居民医保或将并轨

2017-05-25 丰西西 金羊网

广东省卫生计生委相关负责人,对《广东省“十三五”深化医药卫生体制改革规划》这一政策进行了全面解读。

广东出台“十三五”深化医药卫生体制改革规划

日前,省政府出台广东省“十三五”深化医药卫生体制改革规划,对今后一个时期广东医疗卫生事业发展作出全面部署。24日,省卫生计生委相关负责人对这一政策进行全面解读

医保补助逐步提高

目前广东正在研究整合职工基本医疗保险和城乡居民基本医疗保险,“十三五”期间,要实行覆盖范围、筹资标准、待遇水平、支付范围、基金管理、经办服务“六统一”。另外,医保政府补助标准会逐步提高,个人缴费水平也要适当提高。

广东省正在组建省医保基金管理中心,主要承担基金支付和管理,药品采购和费用结算,医保支付标准谈判,定点机构的协议管理和结算等职能。

人均预期寿命77.8岁

广东“十三五”医改的主要目标是什么?

到2017年底,全省基层医疗卫生服务基础设施条件显着改善,服务能力明显提升,基本形成较为系统的基本医疗卫生制度政策框架。到2020年,全面完成基层医疗卫生补短板任务,覆盖城乡居民的基本医疗卫生制度进一步完善,实现人人享有基本医疗卫生服务,基本适应人民群众多层次的医疗卫生需求。全省居民人均预期寿命提高到77.8岁,孕产妇死亡率下降到15/10万以下,婴儿死亡率下降到6‰以下,5岁以下儿童死亡率下降到8‰以下,个人卫生支出占卫生总费用的比重下降到25%以下。

住院诊疗全程监控

加快推动行业信用体系建设。2018年前,建立全省医院和医师执业监管信息系统,执业医师实行代码唯一制,将执业行为与医师信用评价挂钩。同时,利用信息化手段对所有医疗机构门诊、住院诊疗行为和费用开展全程监控和智能审核。全面建立医保医疗服务智能审核系统,对医疗服务和医疗费用实现事前提示、事中监控预警、事后审核和责任追溯。

多措施推动医药分开

药品供应保障制度改革方面,严格落实市场准入和药品注册审查审批制度,规范药品供应流通秩序。推进公立医院药品分类采购。加强省药品第三方电子交易平台建设,提高药品集中采购平台服务和监管能力,健全采购信息采集共享机制。

每种药品采购的剂型原则上不超过3种,每种剂型对应的规格原则上不超过2种。落实药品采购“两票制”。

采取综合措施推动医药分开,切断医院和医务人员与药品、医用耗材间的利益链。医疗机构不得限制处方外流,患者可凭处方到零售药店购药。

同时,要加强对市场竞争不充分的药品和高值医用耗材的价格监管。强化药品价格行为监管,建立健全药品价格信息监测预警和信息发布制度。建立药品生产经营主体及其产品的溯源信息体系,努力实现药品从出厂到患者的每个环节来源可溯、去向可查。

大医院都建医联体

“十三五”期间,广东将全面启动多种形式的医疗联合体建设。城市的三级大型医院要全部参与医联体建设,并发挥引领作用,推动优质医疗资源共享和下沉基层。逐步推行县镇医疗卫生服务一体化管理,以县级医院为龙头,县级医院对乡镇卫生院在人事、财务后勤、资产、业务、药品耗材等进行统一管理。此外,建立区域卫生资源共享机制。到2017年底,实现同级医疗机构间以及医疗机构与独立检查检验机构间检查检验结果互认。

人人有家庭医生

建立分级诊疗制度是医改的重中之重。广东分级诊疗制度建设将从哪些方面发力?

该负责人表示,强基层是主旋律。

从2016年起,省财政三年统筹安排112亿元,重点支持县级公立医院关键设备购置、远程医疗建设等项目。此外,2017年-2019年,广东各级财政将投入500亿元,重点投向粤东西北地区县及县以下医疗卫生机构基础设施建设、人才队伍建设、改善基层服务模式等,特别是县级医院建设、乡镇卫生院标准化建设和妇女儿童医疗机构建设。

另外,家庭医生签约服务制度优先覆盖老年人、孕产妇、儿童、残疾人等人群,以及高血压糖尿病、结核病等慢性病和严重精神障碍患者。到2017年底,家庭医生签约服务覆盖率达到30%以上,重点人群签约服务覆盖率达到60%以上。到2020年,力争将签约服务扩大到全人群,基本实现家庭医生签约服务制度全覆盖。

从2017年起,广东为每个乡镇卫生院和社区卫生服务中心设置2个全科医生特设岗位,除享受单位发放的绩效工资和各项津补贴外,省财政给予每岗每年补助6万元。此外,基层医疗卫生机构可直接将经过规范化培训的全科医生纳入编制管理。

医疗机构同标准监管

医疗服务监管是“十三五”期间要重点推进的医改任务。

要推进属地化和全行业管理,所有医疗卫生机构,不论所有制、投资主体、隶属关系和经营性质,均由所在地卫生计生行政部门按照统一的进入条件、质量标准、服务标准进行监管。同时,加强对非营利性社会办医疗机构产权归属、财务运营、资金结余使用等方面的监督管理,加强对营利性医疗机构盈利率的管控,加强医疗养生类节目和医疗广告监管。

放开部分服务价格

今年7月前全省各级各类公立医院都要取消药品加成(不含中药饮片),通过调整医疗服务价格、加大政府投入、改革支付方式、降低医院运行成本等,建立科学合理的补偿机制。放开特需医疗服务和其他市场竞争比较充分、个性化需求比较强的医疗服务价格,由医疗机构自主制定。

救助因病致贫患者

医保支付方式将实行以按病种付费为主,按人头、按床日、总额预付等多种付费方式相结合的复合型付费方式,鼓励实行按疾病诊断相关分组付费(DRGs)方式,推进支付方式科学化、精细化、标准化管理。重点推行按病种付费,实行同病种同费用,引导常见病、多发病在基层医院诊治。

将保障对象从城乡居民医保向职工医保参保人群延伸,逐步提高大病保障水平并向贫困人群倾斜,提高大病保险对贫困人群支付的精准性。全面开展重特大疾病医疗救助工作,将低收入家庭的老年人、未成年人、重度残疾人、重病患者等低收入救助对象,以及因病致贫家庭重病患者纳入救助范围。

公立医院可年薪制

在珠三角部分城市三级甲等公立医院开展编制管理改革、实行人员总量管理试点。落实公立医院用人自主权。结合实际合理确定公立医院薪酬水平,逐步提高人员经费支出占业务支出的比例,2018年提高到40%。按照有关规定,公立医院可以探索实行目标年薪制和协议薪酬。

医疗费用增长不超10%

要严控医疗费用不合理增长。全省2017年底医疗费用增长控制目标是10%以下。以设区的市为单位向社会公开辖区内各医院的价格、医疗服务效率、次均医疗费用等信息。

公立医院信息公开

下一步公立医院综合改革将如何改?

“十三五”期间,公立医院改革的目标是要建立现代医院管理制度。要落实公立医院自主权。妥善处理医院和政府的关系,实行政事分开和管办分开,推动医院管理模式和运行方式转变。建立健全公立医院全面预算管理制度、成本核算制度、财务报告制度、总会计师制度、第三方审计制度和信息公开制度。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-05-26 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-05-26 方舒

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-05-25 执着追梦

    学习,感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2056814, encodeId=556c2056814fc, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Jul 25 12:35:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408921, encodeId=20c214089219b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534912, encodeId=1cef1534912fe, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Fri May 26 23:35:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202775, encodeId=645c202e75b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KiblTyxD95ExbzUoCVcRuhPibXboL28wicFMTXUhCA0RWCyQZYC5Na3ap7CxjialMkB50VEJ0XToQQTC/0, createdBy=470c1945776, createdName=方舒, createdTime=Fri May 26 12:40:50 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202352, encodeId=b5e920235239, content=学习,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 25 08:52:27 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202350, encodeId=1f932023500e, content=改革,因地制宜, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Thu May 25 08:49:46 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-05-25 lyh994

    改革,因地制宜

    0

相关资讯

北京朝阳区“用药短缺登记制”社区医院按需供药

机构内部建立了用药短缺登记制度,在微信平台上也有登记窗口,对于患者反映的品种可以进行缺货登记,根据登记情况及时调整药品采购品种,方便广大群众的需求。

北京市卫计委:督查故意少开药让患者“多挂号”行为

同样的药量以前挂一次号可以开齐,现在需要分多次挂号。患者表示困惑:“医院是不是为了多挂号而刻意减少开药量”?

北京市3600多家医疗机构正式推行医药分开综合改革

北京市3600多家医疗机构将从今天起正式推行医药分开综合改革。今天0点开始,北京医院的收费系统,将有所调整。

医药分开:一条双赢之路

4月8日,《北京市医药分开综合改革实施方案》(以下简称《方案》)正式实施。《方案》实施近两周来,总体继续保持平稳有序,符合改革预期。有数据显示,从4月8日零时起至4月17日24时,累积节约药品费用约1.5亿元,节省幅度达8.5%;三级医院总门急诊量为260.5万人次,与去年同期相比减少15.1%;二级医院总门急诊量为73.8万人次,与去年同期相比减少6.1%;一级医院及社区服务中心门急诊量为2

全面实行医药分开公立医院如何适应 中国医改还有哪些难点

中国医疗市场结构不合理、医药分开对公立医院的挑战、医联体改革与分级诊疗体系的构建,这些都是中国医改的难点所在。

北京医改首日探访:挂号费取消 患者感受价格变化

4月8日是《北京市医药分开综合改革实施方案》正式实施的首日,这一天起,北京3600多家医疗机构全部取消药品加成(不含中药饮片)和挂号费、诊疗费,设立医事服务费,实现补偿机制转换。那么,北京医改首日,就诊的患者能否感受到相关变化呢?8日,记者在北京多家医院进行了探访。北京协和医院门诊楼一楼医改咨询台。汤琪 摄医事服务费怎么收?——医保患者二级医院普通门诊自付2元根据北京市医改新政,公立医疗机构将取消